Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received an average rating of “Buy” from the twelve brokerages that are presently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and four have assigned a strong buy rating to the company. The average twelve-month target […]
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received an average rating of “Buy” from the twelve brokerages that are presently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and four have assigned a strong buy rating to the company. The average twelve-month target […]
